{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T12:19:05Z","timestamp":1788265145163,"version":"build-2803163510"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T00:00:00Z","timestamp":1624924800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T00:00:00Z","timestamp":1624924800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002794","name":"Cancerfonden","doi-asserted-by":"publisher","award":["180787"],"award-info":[{"award-number":["180787"]}],"id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004047","name":"Karolinska Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The aim of this study was\u00a0to explore the male predominance in esophageal and gastric adenocarcinoma by evaluating the preventive potential of androgen deprivation therapy (ADT). This matched cohort study was based on a national Swedish database of prostate cancer patients in 2006\u20132013. Prostate cancer patients receiving ADT were the exposed group. Prostate cancer-free men from the general population were randomly selected and matched to the index case by birth year and county of residence, forming the unexposed control group. The participants were followed until a diagnosis of esophageal or gastric cancer, death, emigration, or end of the study period. The risk of esophageal adenocarcinoma, cardia gastric adenocarcinoma, non-cardia gastric adenocarcinoma, and esophageal squamous-cell carcinoma among ADT-exposed compared to unexposed was calculated by multivariable Cox proportional hazard regression. The hazard ratios (HRs) and 95% confidence intervals (CIs) were adjusted for confounders. There was a risk reduction of non-cardia gastric adenocarcinoma among ADT-users compared to non-users (HR 0.49 [95% CI 0.24\u20130.98]). No such decreased risk was found for esophageal adenocarcinoma (HR 1.17 [95% CI 0.60\u20132.32]), cardia gastric adenocarcinoma (HR 0.99 [95% CI 0.40\u20132.46]), or esophageal squamous cell carcinoma (HR 0.99 [95% CI 0.31\u20133.13]). This study indicates that androgen deprivation therapy decreases the risk of non-cardia gastric adenocarcinoma, while no decreased risk was found for esophageal adenocarcinoma, cardia gastric adenocarcinoma, or esophageal squamous-cell carcinoma.<\/jats:p>","DOI":"10.1038\/s41598-021-92347-0","type":"journal-article","created":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T10:07:24Z","timestamp":1624961244000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Risk of esophageal and gastric adenocarcinoma in men receiving androgen deprivation therapy for prostate cancer"],"prefix":"10.1038","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2043-8635","authenticated-orcid":false,"given":"Richard","family":"Shore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingru","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weimin","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesper","family":"Lagergren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Ruteg\u00e5rd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olof","family":"Akre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e4r","family":"Stattin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mats","family":"Lindblad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,29]]},"reference":[{"issue":"2","key":"92347_CR1","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3322\/caac.21262","volume":"65","author":"LA Torre","year":"2015","unstructured":"Torre, L. A. et al. Global cancer statistics, 2012. CA Cancer J. Clin. 65(2), 87\u2013108. https:\/\/doi.org\/10.3322\/caac.21262 (2015).","journal-title":"CA Cancer J. Clin."},{"issue":"11","key":"92347_CR2","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1056\/nejm199903183401101","volume":"340","author":"J Lagergren","year":"1999","unstructured":"Lagergren, J., Bergstrom, R., Lindgren, A. & Nyren, O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N. Engl. J. Med. 340(11), 825\u2013831. https:\/\/doi.org\/10.1056\/nejm199903183401101 (1999).","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"92347_CR3","doi-asserted-by":"publisher","first-page":"883","DOI":"10.7326\/0003-4819-130-11-199906010-00003","volume":"130","author":"J Lagergren","year":"1999","unstructured":"Lagergren, J., Bergstrom, R. & Nyren, O. Association between body mass and adenocarcinoma of the esophagus and gastric cardia. Ann. Intern Med. 130(11), 883\u2013890 (1999).","journal-title":"Ann. Intern Med."},{"issue":"3","key":"92347_CR4","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s10552-004-3485-7","volume":"16","author":"M Lindblad","year":"2005","unstructured":"Lindblad, M., Rodriguez, L. A. & Lagergren, J. Body mass, tobacco and alcohol and risk of esophageal, gastric cardia, and gastric non-cardia adenocarcinoma among men and women in a nested case-control study. Cancer Causes Control 16(3), 285\u2013294. https:\/\/doi.org\/10.1007\/s10552-004-3485-7 (2005).","journal-title":"Cancer Causes Control"},{"issue":"5","key":"92347_CR5","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1086\/427659","volume":"191","author":"C de Martel","year":"2005","unstructured":"de Martel, C. et al. Helicobacter pylori infection and the risk of development of esophageal adenocarcinoma. J. Infect. Dis. 191(5), 761\u2013767. https:\/\/doi.org\/10.1086\/427659 (2005).","journal-title":"J. Infect. Dis."},{"issue":"10","key":"92347_CR6","doi-asserted-by":"publisher","first-page":"2559","DOI":"10.1002\/ijc.21678","volume":"118","author":"CA Gonzalez","year":"2006","unstructured":"Gonzalez, C. A. et al. Fruit and vegetable intake and the risk of stomach and oesophagus adenocarcinoma in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST). Int. J. Cancer 118(10), 2559\u20132566. https:\/\/doi.org\/10.1002\/ijc.21678 (2006).","journal-title":"Int. J. Cancer"},{"issue":"10","key":"92347_CR7","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1136\/gutjnl-2012-302412","volume":"62","author":"G Edgren","year":"2013","unstructured":"Edgren, G., Adami, H. O., Weiderpass, E. & Nyren, O. A global assessment of the oesophageal adenocarcinoma epidemic. Gut 62(10), 1406\u20131414. https:\/\/doi.org\/10.1136\/gutjnl-2012-302412 (2013).","journal-title":"Gut"},{"issue":"10110","key":"92347_CR8","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1016\/s0140-6736(17)31462-9","volume":"390","author":"J Lagergren","year":"2017","unstructured":"Lagergren, J., Smyth, E., Cunningham, D. & Lagergren, P. Oesophageal cancer. Lancet 390(10110), 2383\u20132396. https:\/\/doi.org\/10.1016\/s0140-6736(17)31462-9 (2017).","journal-title":"Lancet"},{"issue":"3","key":"92347_CR9","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.cgh.2015.10.005","volume":"14","author":"SH Xie","year":"2016","unstructured":"Xie, S. H. & Lagergren, J. The male predominance in esophageal adenocarcinoma. Clin. Gastroenterol. Hepatol. 14(3), 338. https:\/\/doi.org\/10.1016\/j.cgh.2015.10.005 (2016).","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"12","key":"92347_CR10","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1136\/gutjnl-2014-308915","volume":"64","author":"A Colquhoun","year":"2015","unstructured":"Colquhoun, A. et al. Global patterns of cardia and non-cardia gastric cancer incidence in 2012. Gut 64(12), 1881-U1871 (2015).","journal-title":"Gut"},{"issue":"6","key":"92347_CR11","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1002\/ijc.10427","volume":"99","author":"AP Vizcaino","year":"2002","unstructured":"Vizcaino, A. P., Moreno, V., Lambert, R. & Parkin, D. M. Time trends incidence of both major histologic types of esophageal carcinomas in selected countries, 1973\u20131995. Int. J. Cancer 99(6), 860\u2013868. https:\/\/doi.org\/10.1002\/ijc.10427 (2002).","journal-title":"Int. J. Cancer"},{"issue":"2","key":"92347_CR12","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1002\/ijc.28999","volume":"136","author":"M Plummer","year":"2015","unstructured":"Plummer, M., Franceschi, S., Vignat, J., Forman, D. & de Martel, C. Global burden of gastric cancer attributable to Helicobacter pylori. Int. J. Cancer 136(2), 487\u2013490. https:\/\/doi.org\/10.1002\/ijc.28999 (2015).","journal-title":"Int. J. Cancer"},{"issue":"3","key":"92347_CR13","doi-asserted-by":"publisher","first-page":"354","DOI":"10.3748\/wjg.v12.i3.354","volume":"12","author":"KD Crew","year":"2006","unstructured":"Crew, K. D. & Neugut, A. I. Epidemiology of gastric cancer. World J. Gastroenterol. 12(3), 354\u2013362 (2006).","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"92347_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0895-4356(02)00534-6","volume":"56","author":"JR Kelley","year":"2003","unstructured":"Kelley, J. R. & Duggan, J. M. Gastric cancer epidemiology and risk factors. J. Clin. Epidemiol. 56(1), 1\u20139 (2003).","journal-title":"J. Clin. Epidemiol."},{"issue":"4","key":"92347_CR15","doi-asserted-by":"publisher","first-page":"232","DOI":"10.3322\/caac.21185","volume":"63","author":"J Lagergren","year":"2013","unstructured":"Lagergren, J. & Lagergren, P. Recent developments in esophageal adenocarcinoma. Ca Cancer J. Clin. 63(4), 232\u2013248. https:\/\/doi.org\/10.3322\/caac.21185 (2013).","journal-title":"Ca Cancer J. Clin."},{"issue":"16","key":"92347_CR16","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1016\/j.ejca.2008.07.031","volume":"44","author":"E Chandanos","year":"2008","unstructured":"Chandanos, E. & Lagergren, J. Oestrogen and the enigmatic male predominance of gastric cancer. Eur. J. Cancer 44(16), 2397\u20132403. https:\/\/doi.org\/10.1016\/j.ejca.2008.07.031 (2008).","journal-title":"Eur. J. Cancer"},{"issue":"4","key":"92347_CR17","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s101200200037","volume":"5","author":"P Sipponen","year":"2002","unstructured":"Sipponen, P. & Correa, P. Delayed rise in incidence of gastric cancer in females results in unique sex ratio (M\/F) pattern: Etiologic hypothesis. Gastric Cancer 5(4), 213\u2013219. https:\/\/doi.org\/10.1007\/s101200200037 (2002).","journal-title":"Gastric Cancer"},{"issue":"6","key":"92347_CR18","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/j.ejca.2010.01.029","volume":"46","author":"M Rutegard","year":"2010","unstructured":"Rutegard, M., Shore, R., Lu, Y. X., Lagergren, P. & Lindblad, M. Sex differences in the incidence of gastrointestinal adenocarcinoma in Sweden 1970\u20132006. Eur. J. Cancer 46(6), 1093\u20131100. https:\/\/doi.org\/10.1016\/j.ejca.2010.01.029 (2010).","journal-title":"Eur. J. Cancer"},{"issue":"1","key":"92347_CR19","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1093\/ije\/dyv305","volume":"45","author":"M Van Hemelrijck","year":"2016","unstructured":"Van Hemelrijck, M., Garmo, H., Wigertz, A., Nilsson, P. & Stattin, P. Cohort profile update: The national prostate cancer register of Sweden and prostate cancer data base\u2014a refined prostate cancer trajectory. Int. J. Epidemiol. 45(1), 73\u201382. https:\/\/doi.org\/10.1093\/ije\/dyv305 (2016).","journal-title":"Int. J. Epidemiol."},{"issue":"2","key":"92347_CR20","doi-asserted-by":"publisher","first-page":"158","DOI":"10.3109\/0284186x.2014.939299","volume":"54","author":"K Tomic","year":"2015","unstructured":"Tomic, K. et al. Capture rate and representativity of The National Prostate Cancer Register of Sweden. Acta Oncol. 54(2), 158\u2013163. https:\/\/doi.org\/10.3109\/0284186x.2014.939299 (2015).","journal-title":"Acta Oncol."},{"issue":"1","key":"92347_CR21","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.ejca.2014.10.025","volume":"51","author":"K Tomic","year":"2015","unstructured":"Tomic, K. et al. Evaluation of data quality in the National Prostate Cancer Register of Sweden. Eur. J. Cancer 51(1), 101\u2013111. https:\/\/doi.org\/10.1016\/j.ejca.2014.10.025 (2015).","journal-title":"Eur. J. Cancer"},{"key":"92347_CR22","unstructured":"Longitudinal integration database for health insurance and labour market studies (LISA by Swedish acronym) Statistics Sweden. http:\/\/www.scb.se\/en\/services\/guidance-for-researchers-and-universities\/vilka-mikrodata-finns\/longitudinella-register\/longitudinal-integration-database-for-health-insurance-and-labour-market-studies-lisa\/."},{"issue":"4","key":"92347_CR23","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1080\/00365590802078583","volume":"42","author":"K Fall","year":"2008","unstructured":"Fall, K., Stromberg, F., Rosell, J., Andren, O. & Varenhorst, E. Reliability of death certificates in prostate cancer patients. Scand. J. Urol. Nephrol. 42(4), 352\u2013357. https:\/\/doi.org\/10.1080\/00365590802078583 (2008).","journal-title":"Scand. J. Urol. Nephrol."},{"issue":"4","key":"92347_CR24","doi-asserted-by":"publisher","first-page":"226","DOI":"10.3109\/00365599.2011.559950","volume":"45","author":"R Godtman","year":"2011","unstructured":"Godtman, R., Holmberg, E., Stranne, J. & Hugosson, J. High accuracy of Swedish death certificates in men participating in screening for prostate cancer: A comparative study of official death certificates with a cause of death committee using a standardized algorithm. Scand. J. Urol. Nephrol. 45(4), 226\u2013232. https:\/\/doi.org\/10.3109\/00365599.2011.559950 (2011).","journal-title":"Scand. J. Urol. Nephrol."},{"issue":"7","key":"92347_CR25","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1002\/pds.1294","volume":"16","author":"B Wettermark","year":"2007","unstructured":"Wettermark, B. et al. The new Swedish Prescribed Drug Register\u2014opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol. Drug Saf. 16(7), 726\u2013735. https:\/\/doi.org\/10.1002\/pds.1294 (2007).","journal-title":"Pharmacoepidemiol. Drug Saf."},{"issue":"9","key":"92347_CR26","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1093\/jnci\/91.9.786","volume":"91","author":"AM Ekstrom","year":"1999","unstructured":"Ekstrom, A. M. et al. Evaluating gastric cancer misclassification: A potential explanation for the rise in cardia cancer incidence. J. Natl. Cancer Inst. 91(9), 786\u2013790. https:\/\/doi.org\/10.1093\/jnci\/91.9.786 (1999).","journal-title":"J. Natl. Cancer Inst."},{"issue":"4","key":"92347_CR27","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1097\/01.sla.0000205825.34452.43","volume":"243","author":"M Lindblad","year":"2006","unstructured":"Lindblad, M., Ye, W. M., Lindgren, A. S. & Lagergren, J. Disparities in the classification of esophageal and cardia adenocarcinomas and their influence on reported incidence rates. Ann. Surg. 243(4), 479\u2013485. https:\/\/doi.org\/10.1097\/01.sla.0000205825.34452.43 (2006).","journal-title":"Ann. Surg."},{"issue":"12","key":"92347_CR28","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1158\/1055-9965.2203.13.12","volume":"13","author":"M Lindblad","year":"2004","unstructured":"Lindblad, M., Ye, W., Rubio, C. & Lagergren, J. Estrogen and risk of gastric cancer: A protective effect in a nationwide cohort study of patients with prostate cancer in Sweden. Cancer Epidemiol. Biomarkers. Prev. 13(12), 2203\u20132207 (2004).","journal-title":"Cancer Epidemiol. Biomarkers. Prev."},{"issue":"10 Suppl","key":"92347_CR29","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1002\/cncr.20408","volume":"101","author":"DG Bostwick","year":"2004","unstructured":"Bostwick, D. G. et al. Human prostate cancer risk factors. Cancer 101(10 Suppl), 2371\u20132490. https:\/\/doi.org\/10.1002\/cncr.20408 (2004).","journal-title":"Cancer"},{"issue":"8","key":"92347_CR30","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1007\/s10552-009-9359-2","volume":"20","author":"SC Cooper","year":"2009","unstructured":"Cooper, S. C., Croft, S., Day, R., Thomson, C. S. & Trudgill, N. J. Patients with prostate cancer are less likely to develop oesophageal adenocarcinoma: Could androgens have a role in the aetiology of oesophageal adenocarcinoma?. Cancer Causes Control 20(8), 1363\u20131368. https:\/\/doi.org\/10.1007\/s10552-009-9359-2 (2009).","journal-title":"Cancer Causes Control"},{"issue":"24","key":"92347_CR31","doi-asserted-by":"publisher","first-page":"6207","DOI":"10.1002\/cncr.27672","volume":"118","author":"M Van Hemelrijck","year":"2012","unstructured":"Van Hemelrijck, M. et al. Primary cancers before and after prostate cancer diagnosis. Cancer 118(24), 6207\u20136216. https:\/\/doi.org\/10.1002\/cncr.27672 (2012).","journal-title":"Cancer"},{"issue":"12","key":"92347_CR32","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1007\/s00228-012-1290-x","volume":"68","author":"B Grundmark","year":"2012","unstructured":"Grundmark, B. et al. Anti-androgen prescribing patterns, patient treatment adherence and influencing factors; results from the nationwide PCBaSe Sweden. Eur. J. Clin. Pharmacol. 68(12), 1619\u20131630. https:\/\/doi.org\/10.1007\/s00228-012-1290-x (2012).","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"10","key":"92347_CR33","first-page":"913","volume":"7","author":"J Lagergren","year":"1998","unstructured":"Lagergren, J. & Nyren, O. Do sex hormones play a role in the etiology of esophageal adenocarcinoma? A new hypothesis tested in a population-based cohort of prostate cancer patients. Cancer Epidemiol. Biomark. Prev. 7(10), 913\u2013915 (1998).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"issue":"10","key":"92347_CR34","first-page":"779","volume":"6","author":"H Ahsan","year":"1997","unstructured":"Ahsan, H., Neugut, A. I. & Gammon, M. D. Association of adenocarcinoma and squamous cell carcinoma of the esophagus with tobacco-related and other malignancies. Cancer Epidemiol. Biomark. Prev. 6(10), 779\u2013782 (1997).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"issue":"6","key":"92347_CR35","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1007\/s10552-012-9950-9","volume":"23","author":"SC Cooper","year":"2012","unstructured":"Cooper, S. C. & Trudgill, N. J. Subjects with prostate cancer are less likely to develop esophageal cancer: Analysis of SEER 9 registries database. Cancer Causes Control 23(6), 819\u2013825. https:\/\/doi.org\/10.1007\/s10552-012-9950-9 (2012).","journal-title":"Cancer Causes Control"},{"issue":"1","key":"92347_CR36","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/sj.bjc.6602906","volume":"94","author":"M Lindblad","year":"2006","unstructured":"Lindblad, M., Rodriguez, L. A. G., Chandanos, E. & Lagergren, J. Hormone replacement therapy and risks of oesophageal and gastric adenocarcinomas. Br. J. Cancer 94(1), 136\u2013141. https:\/\/doi.org\/10.1038\/sj.bjc.6602906 (2006).","journal-title":"Br. J. Cancer"},{"issue":"5","key":"92347_CR37","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1177\/2050640614543736","volume":"2","author":"S Menon","year":"2014","unstructured":"Menon, S., Nightingale, P. & Trudgill, N. Is hormone replacement therapy in post-menopausal women associated with a reduced risk of oesophageal cancer?. United Eur. Gastroenterol. J. 2(5), 374\u2013382. https:\/\/doi.org\/10.1177\/2050640614543736 (2014).","journal-title":"United Eur. Gastroenterol. J."},{"issue":"9","key":"92347_CR38","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1002\/ijc.28869","volume":"135","author":"K Lagergren","year":"2014","unstructured":"Lagergren, K., Lagergren, J. & Brusselaers, N. Hormone replacement therapy and oral contraceptives and risk of oesophageal adenocarcinoma: A systematic review and meta-analysis. Int. J. Cancer 135(9), 2183\u20132190. https:\/\/doi.org\/10.1002\/ijc.28869 (2014).","journal-title":"Int. J. Cancer"},{"issue":"7","key":"92347_CR39","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1002\/ijc.30588","volume":"140","author":"N Brusselaers","year":"2017","unstructured":"Brusselaers, N., Maret-Ouda, J., Konings, P., El-Serag, H. B. & Lagergren, J. Menopausal hormone therapy and the risk of esophageal and gastric cancer. Int. J. Cancer 140(7), 1693\u20131699. https:\/\/doi.org\/10.1002\/ijc.30588 (2017).","journal-title":"Int. J. Cancer"},{"issue":"11","key":"92347_CR40","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1016\/j.ejca.2010.03.032","volume":"46","author":"DP Cronin-Fenton","year":"2010","unstructured":"Cronin-Fenton, D. P. et al. Reproductive and sex hormonal factors and oesophageal and gastric junction adenocarcinoma: A pooled analysis. Eur. J. Cancer 46(11), 2067\u20132076. https:\/\/doi.org\/10.1016\/j.ejca.2010.03.032 (2010).","journal-title":"Eur. J. Cancer"},{"issue":"5","key":"92347_CR41","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1111\/dote.12349","volume":"29","author":"BJ Wang","year":"2016","unstructured":"Wang, B. J. et al. Hormonal and reproductive factors and risk of esophageal cancer in women: A meta-analysis. Dis. Esophagus 29(5), 448\u2013454. https:\/\/doi.org\/10.1111\/dote.12349 (2016).","journal-title":"Dis. Esophagus"},{"issue":"1","key":"92347_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/cej.0000000000000234","volume":"26","author":"YH Zhu","year":"2017","unstructured":"Zhu, Y. H., Yue, D. H., Yuan, B. B., Zhu, L. H. & Lu, M. Reproductive factors are associated with oesophageal cancer risk: Results from a meta-analysis of observational studies. Eur. J. Cancer Prev. 26(1), 1\u20139. https:\/\/doi.org\/10.1097\/cej.0000000000000234 (2017).","journal-title":"Eur. J. Cancer Prev."},{"issue":"7","key":"92347_CR43","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.ejca.2008.02.049","volume":"44","author":"E Chandanos","year":"2008","unstructured":"Chandanos, E. et al. Tamoxifen exposure in relation to gastric adenocarcinoma development. Eur. J. Cancer 44(7), 1007\u20131014. https:\/\/doi.org\/10.1016\/j.ejca.2008.02.049 (2008).","journal-title":"Eur. J. Cancer"},{"issue":"12","key":"92347_CR44","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1136\/gut.2007.129411","volume":"56","author":"ND Freedman","year":"2007","unstructured":"Freedman, N. D. et al. Menstrual and reproductive factors and gastric cancer risk in a large prospective study of women. Gut 56(12), 1671\u20131677. https:\/\/doi.org\/10.1136\/gut.2007.129411 (2007).","journal-title":"Gut"},{"issue":"12","key":"92347_CR45","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/j.annepidem.2006.03.001","volume":"16","author":"S Frise","year":"2006","unstructured":"Frise, S., Kreiger, N., Gallinger, S., Tomlinson, G. & Cotterchio, M. Menstrual and reproductive risk factors and risk for gastric adenocarcinoma in women: Findings from the Canadian national enhanced cancer surveillance system. Ann. Epidemiol. 16(12), 908\u2013916. https:\/\/doi.org\/10.1016\/j.annepidem.2006.03.001 (2006).","journal-title":"Ann. Epidemiol."},{"issue":"1","key":"92347_CR46","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1023\/A:1022596104796","volume":"14","author":"S Kaneko","year":"2003","unstructured":"Kaneko, S., Tamakoshi, A., Ohno, Y., Mizoue, T. & Yoshimura, T. Menstrual and reproductive factors and the mortality risk of gastric cancer in Japanese menopausal females. Cancer Causes Control 14(1), 53\u201359 (2003).","journal-title":"Cancer Causes Control"},{"issue":"6","key":"92347_CR47","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1002\/ijc.2910590609","volume":"59","author":"C La Vecchia","year":"1994","unstructured":"La Vecchia, C. et al. Menstrual and reproductive factors and gastric-cancer risk in women. Int. J. Cancer 59(6), 761\u2013764 (1994).","journal-title":"Int. J. Cancer"},{"issue":"12","key":"92347_CR48","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1093\/oxfordjournals.annonc.a010406","volume":"11","author":"Y Matsuyama","year":"2000","unstructured":"Matsuyama, Y. et al. Second cancers after adjuvant tamoxifen therapy for breast cancer in Japan. Ann. Oncol. 11(12), 1537\u20131543 (2000).","journal-title":"Ann. Oncol."},{"issue":"1","key":"92347_CR49","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/sj.bjc.6603214","volume":"95","author":"E Chandanos","year":"2006","unstructured":"Chandanos, E. et al. Tamoxifen exposure and risk of oesophageal and gastric adenocarcinoma: A population-based cohort study of breast cancer patients in Sweden. Br. J. Cancer 95(1), 118\u2013122. https:\/\/doi.org\/10.1038\/sj.bjc.6603214 (2006).","journal-title":"Br. J. Cancer"},{"issue":"8","key":"92347_CR50","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1097\/mcg.0000000000000262","volume":"49","author":"S Chen","year":"2015","unstructured":"Chen, S., Liu, H., Li, J. & Yang, G. Risk of gastric and colorectal cancer after tamoxifen use for breast cancer: A systematic review and meta-analysis. J. Clin. Gastroenterol. 49(8), 666\u2013674. https:\/\/doi.org\/10.1097\/mcg.0000000000000262 (2015).","journal-title":"J. Clin. Gastroenterol."},{"issue":"1","key":"92347_CR51","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1158\/1055-9965.epi-11-0834","volume":"21","author":"MC Camargo","year":"2012","unstructured":"Camargo, M. C. et al. Sex hormones, hormonal interventions, and gastric cancer risk: A meta-analysis. Cancer Epidemiol. Biomark. Prev. 21(1), 20\u201338. https:\/\/doi.org\/10.1158\/1055-9965.epi-11-0834 (2012).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"issue":"6","key":"92347_CR52","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1111\/dote.12000","volume":"26","author":"OA Sukocheva","year":"2013","unstructured":"Sukocheva, O. A., Wee, C., Ansar, A., Hussey, D. J. & Watson, D. I. Effect of estrogen on growth and apoptosis in esophageal adenocarcinoma cells. Dis. Esophagus 26(6), 628\u2013635. https:\/\/doi.org\/10.1111\/dote.12000 (2013).","journal-title":"Dis. Esophagus"},{"issue":"1\u20132","key":"92347_CR53","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.mce.2009.03.016","volume":"307","author":"AM Hogan","year":"2009","unstructured":"Hogan, A. M., Collins, D., Baird, A. W. & Winter, D. C. Estrogen and gastrointestinal malignancy. Mol. Cell Endocrinol. 307(1\u20132), 19\u201324. https:\/\/doi.org\/10.1016\/j.mce.2009.03.016 (2009).","journal-title":"Mol. Cell Endocrinol."},{"key":"92347_CR54","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.16582","author":"W Tang","year":"2017","unstructured":"Tang, W. et al. Expression of estrogen receptors and androgen receptor and their clinical significance in gastric cancer. Oncotarget https:\/\/doi.org\/10.18632\/oncotarget.16582 (2017).","journal-title":"Oncotarget"},{"issue":"12","key":"92347_CR55","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.1016\/j.cgh.2019.11.030","volume":"18","author":"SH Xie","year":"2020","unstructured":"Xie, S. H. et al. Association between levels of sex hormones and risk of esophageal adenocarcinoma and Barrett\u2019s esophagus. Clin. Gastroenterol. Hepatol. 18(12), 2701-2709.e2703. https:\/\/doi.org\/10.1016\/j.cgh.2019.11.030 (2020).","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"1","key":"92347_CR56","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1093\/jnci\/djy082","volume":"111","author":"JL Petrick","year":"2019","unstructured":"Petrick, J. L. et al. Associations between prediagnostic concentrations of circulating sex steroid hormones and esophageal\/gastric cardia adenocarcinoma among men. J. Natl. Cancer Inst. 111(1), 34\u201341. https:\/\/doi.org\/10.1093\/jnci\/djy082 (2019).","journal-title":"J. Natl. Cancer Inst."},{"issue":"2","key":"92347_CR57","doi-asserted-by":"publisher","first-page":"216","DOI":"10.14309\/ajg.0000000000000446","volume":"115","author":"SH Xie","year":"2020","unstructured":"Xie, S. H. et al. Circulating sex hormone levels and risk of esophageal adenocarcinoma in a prospective study in men. Am. J. Gastroenterol. 115(2), 216\u2013223. https:\/\/doi.org\/10.14309\/ajg.0000000000000446 (2020).","journal-title":"Am. J. Gastroenterol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-92347-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-92347-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-92347-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T10:36:41Z","timestamp":1670063801000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-92347-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,29]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["92347"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-92347-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,29]]},"assertion":[{"value":"15 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare  no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13486"}}